Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Nutr Res. 2011 Jan;31(1):61–75. doi: 10.1016/j.nutres.2011.01.001

Table II. Summary of the pharmacologic management of anaphylaxis (modified).

In the outpatient setting
  • First-line treatment:
    • Epinephrine, IM: auto-injector or 1:1,000 solution
      • 10 to 25 kg: 0.15 mg epinephrine autoinjector, IM (anterior-lateral thigh)
      • >25 kg: 0.3 mg epinephrine autoinjector, IM (anterior-lateral thigh)
      • Epinephrine (1:1,000 solution) (IM), 0.01 mg/kg per dose: maximum dose, 0.5 mg per dose (anterior-lateral thigh)
    • Epinephrine doses may need to be repeated every 5-15 minutes
  • Adjunctive treatment:
    • Bronchodilator (b2-agonist): albuterol
      • MDI (child: 4-8 puffs: adult: 8 puffs) or
      • Nebulized solution (child: 1.5 ml: adult: 3 ml) every 20 minutes or continuously as needed
    • H1 antihistamine: diphenhydramine
      • 1 to 2 mg/kg per dose
      • Maximum dose, 50 mg IV or oral (oral liquid is more readily absorbed than tablets)
      • Alternative dosing may be with a less-sedating second generation antihistamine
    • Supplemental oxygen therapy
    • IV fluids in large volumes if patient presents with orthostasis, hypotension, or incomplete response to IM epinephrine
    • Place the patient in recumbent position if tolerated, with the lower extremities elevated

In the hospital-based setting

  • First-line treatment:
    • Epinephrine IM as above, consider continuous epinephrine infusion for persistent hypotension (ideally with continuous non-invasive monitoring of blood pressure and heart rate): alternatives are endotracheal or intra-osseous epinephrine
  • Adjunctive treatment:
    • Bronchodilator (b2-agonist): albuterol
      • MDI (child: 4-8 puffs: adult: 8 puffs) or
      • Nebulized solution (child: 1.5 ml: adult: 3 ml) every 20 minutes or continuously as needed
    • H1 antihistamine: diphenhydramine
      • 1 to 2 mg/kg per dose
      • Maximum dose, 50 mg IV or oral (oral liquid is more readily absorbed than tablets)
      • Alternative dosing may be with a less-sedating second generation antihistamine
    • H2 antihistamine: ranitidine
      • 1 to 2 mg/kg per dose
      • Maximum dose, 75 to 150 mg oral and IV
    • Corticosteroids
      • Prednisone at 1 mg/kg with a maximum dose of 60 to 80 mg oral or
      • Methylprednisolone at 1 mg/kg with a maximum dose of 60 to 80 mg IV
    • Vasopressors (other than epinephrine) for refractory hypotension, titrate to effect
    • Glucagon for refractory hypotension, titrate to effect
      • Child: 20-30 mg/kg
      • Adult: 1-5 mg
      • Dose may be repeated or followed by infusion of 5-15 mg/min
    • Atropine for bradycardia, titrate to effect
    • Supplemental oxygen therapy
    • IV fluids in large volumes if patients present with orthostasis, hypotension, or incomplete response to IM epinephrine
    • Place the patient in recumbent position if tolerated, with the lower extremities elevated

Therapy for the patient at discharge

  • First-line treatment:
    • Epinephrine auto-injector prescription (2 doses) and instructions
    • Education on avoidance of allergen
    • Follow-up with primary care physician
    • Consider referral to an allergist
  • Adjunctive treatment:
    • H1 antihistamine: diphenhydramine every 6 hours for 2-3 days: alternative dosing with a non-sedating second generation antihistamine
    • H2 antihistamine: ranitidine twice daily for 2-3 days
    • Corticosteroid: prednisone daily for 2-3 days

Note: These treatments often occur concomitantly, and are not meant to be sequential, with the exception of epinephrine as first-line treatment.

IM, Intramuscular: IV, intravenous: MDI, metered-dose inhaler.

Note: This table is presented as Table VI in the Guidelines.